Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor

Virology

Volumn 401, Issue 2, 2010, Pages 305-313

  Drouin, Mathieu ^a   Cayer, Marie Pierre ^a   Jung, Daniel ^a,b  

^a HÉMA QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adenovirus; B lymphocytes; Intracellular trafficking

Indexed keywords

CELL SURFACE RECEPTOR; ADENOVIRUS RECEPTOR; CAPSID PROTEIN; HEXON CAPSID PROTEIN, ADENOVIRUS; RECOMBINANT PROTEIN; VIRUS RECEPTOR;

ADENOVIRUS; ADENOVIRUS 5; ADENOVIRUS F35; ARTICLE; B LYMPHOCYTE; CELL TRANSPORT; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS ENTRY; CELL CULTURE; CELL LINE; CYTOSOL; ENDOSOME; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; HUMAN ADENOVIRUS; LYSOSOME; PHYSIOLOGY; VIRAL TROPISM; VIROLOGY;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

ADENOVIRUSES, HUMAN; B-LYMPHOCYTES; CAPSID PROTEINS; CELL LINE; CELLS, CULTURED; CYTOSOL; ENDOSOMES; GENETIC VECTORS; HUMANS; LYSOSOMES; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; VIRAL TROPISM; VIRUS INTERNALIZATION;

EID: 77952298941     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.03.003     Document Type: Article

References (43)

1. Cayer M.P., Drouin M., Sea S.P., Forest A., Cote S., Simard C., Boyer L., Jacques A., Pineault N., Jung D. Comparison of promoter activities for efficient expression into human B cells and haematopoietic progenitors with adenovirus Ad5/F35. J. Immunol. Methods 2007, 322:118-127.
2. Colin M., Renaut L., Mailly L., D'Halluin J.C. Factors involved in the sensitivity of different hematopoietic cell lines to infection by subgroup C adenovirus: implication for gene therapy of human lymphocytic malignancies. Virology 2004, 320:23-39.
3. Colin M., Mailly L., Rogee S., D'Halluin J.C. Efficient species C HAdV infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/caveola endocytic route. Mol. Ther. 2005, 11:224-236.
4. Fecteau J.F., Néron S. CD40 stimulation of human peripheral B lymphocytes: distinct response from naïve and memory cells. J. Immunol. 2003, 171:4621-4629.
5. Gaggar A., Shayakhmetov D.M., Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 2003, 9:1408-1412.
6. Gilbert J.M., Benjamin T.L. Early steps of polyomavirus entry into cells. J. Virol. 2000, 74:8582-8588.
7. Greber U.F., Kasamatsu H. Nuclear targeting of SV40 and adenovirus. Trends Cell Biol. 1996, 6:189-195.
8. Harvey B.P., Quan T.E., Rudenga B.J., Roman R.M., Craft J., Mamula M.J. Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors. J. Immunol. 2008, 181:4043-4051.
9. Havenga M.J., Lemckert A.A., Ophorst O.J., van Meijer M., Germeraad W.T., Grimbergen J., van Den Doel M.A., Vogels R., van Deutekom J., Janson A.A., de Bruijn J.D., Uytdehaag F., Quax P.H., Logtenberg T., Mehtali M., Bout A. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J. Virol. 2002, 76:4612-4620.
10. Huang S., Stupack D., Mathias P., Wang Y., Nemerow G. Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:8156-8161.
11. Jung D., Neron S., Drouin M., Jacques A. Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F35. J. Immunol. Methods 2005, 304:78-87.
12. Kartenbeck J., Stukenbrok H., Helenius A. Endocytosis of simian virus 40 into the endoplasmic reticulum. J. Cell Biol. 1989, 109:2721-2729.
13. Kay M.A., Glorioso J.C., Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 2001, 7:33-40.
14. Knaan-Shanzer S., Van Der Velde I., Havenga M.J., Lemckert A.A., De Vries A.A., Valerio D. Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. Hum. Gene Ther. 2001, 12:1989-2005.
15. Leopold P.L., Crystal R.G. Intracellular trafficking of adenovirus: many means to many ends. Adv. Drug Deliv. Rev. 2007, 59:810-821.
16. Leopold P.L., Ferris B., Grinberg I., Worgall S., Hackett N.R., Crystal R.G. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther. 1998, 9:367-378.
17. Marjomaki V., Pietiainen V., Matilainen H., Upla P., Ivaska J., Nissinen L., Reunanen H., Huttunen P., Hyypia T., Heino J. Internalization of echovirus 1 in caveolae. J. Virol. 2002, 76:1856-1865.
18. McNees A.L., Mahr J.A., Ornelles D., Gooding L.R. Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines. J. Virol. 2004, 78:6955-6966.
19. Miksa M., Komura H., Wu R., Shah K.G., Wang P. A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester. J. Immunol. Methods 2009, 342:71-77.
20. Miyazawa N., Leopold P.L., Hackett N.R., Ferris B., Worgall S., Falck-Pedersen E., Crystal R.G. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 1999, 73:6056-6065.
21. Miyazawa N., Crystal R.G., Leopold P.L. Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 2001, 75:1387-1400.
22. Moore N.M., Sheppard C.L., Barbour T.R., Sakiyama-Elbert S.E. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J. Gene Med. 2008, 10:1134-1149.
23. Neering S.J., Hardy S.F., Minamoto D., Spratt S.K., Jordan C.T. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996, 88:1147-1155.
24. Neron S., Racine C., Roy A., Guerin M. Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction. Immunology 2005, 116:454-463.
25. Nevins J.R., DeGregori J., Jakoi L., Leone G. Functional analysis of E2F transcription factor. Methods Enzymol. 1997, 283:205-219.
26. Nilsson M., Ljungberg J., Richter J., Kiefer T., Magnusson M., Lieber A., Widegren B., Karlsson S., Fan X. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J. Gene Med. 2004, 6:631-641.
27. Pelkmans L., Kartenbeck J., Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 2001, 3:473-483.
28. Pelkmans L., Puntener D., Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 2002, 296:535-539.
29. Rea D., Havenga M.J., van Den Assem M., Sutmuller R.P., Lemckert A., Hoeben R.C., Bout A., Melief C.J., Offringa R. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J. Immunol. 2001, 166:5236-5244.
30. Rebel V.I., Hartnett S., Denham J., Chan M., Finberg R., Sieff C.A. Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells. Stem Cells 2000, 18:176-182.
31. Richterova Z., Liebl D., Horak M., Palkova Z., Stokrova J., Hozak P., Korb J., Forstova J. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J. Virol. 2001, 75:10880-10891.
32. Rogee S., Grellier E., Bernard C., Loyens A., Beauvillain J.C., D'Halluin J.C., Colin M. Intracellular trafficking of a fiber-modified adenovirus using lipid raft/caveolae endocytosis. Mol. Ther. 2007, 15:1963-1972.
33. Schroers R., Hildebrandt Y., Hasenkamp J., Glass B., Lieber A., Wulf G., Piesche M. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp. Hematol. 2004, 32:536-546.
34. Shayakhmetov D.M., Papayannopoulou T., Stamatoyannopoulos G., Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol. 2000, 74:2567-2583.
35. Shayakhmetov D.M., Li Z.Y., Ternovoi V., Gaggar A., Gharwan H., Lieber A. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J. Virol. 2003, 77:3712-3723.
36. Sieczkarski S.B., Whittaker G.R. Dissecting virus entry via endocytosis. J.Gen. Virol. 2002, 83:1535-1545.
37. Tagawa A., Mezzacasa A., Hayer A., Longatti A., Pelkmans L., Helenius A. Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters. J. Cell Biol. 2005, 170:769-779.
38. Thomas J.A., Buchsbaum R.N., Zimniak A., Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979, 18:2210-2218.
39. Thomsen P., Roepstorff K., Stahlhut M., van Deurs B. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol. Biol. Cell 2002, 13:238-250.
40. Werling D., Hope J.C., Chaplin P., Collins R.A., Taylor G., Howard C.J. Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells. J. Leukoc. Biol. 1999, 66:50-58.
41. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993, 73:309-319.
42. Wilson J.M. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 1996, 334:1185-1187.
43. Yotnda P., Zompeta C., Heslop H.E., Andreeff M., Brenner M.K., Marini F. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Hum. Gene Ther. 2004, 15:1229-1242.